申请人:Dainippon Sumitomo Pharma Co., Ltd.
公开号:US07468364B2
公开(公告)日:2008-12-23
Carbapenem compounds represented by the general formula [1] or pharmaceutically acceptable salts thereof:
wherein R1 is C1-C3 alkyl or hydroxylated C1-C3 alkyl, R is hydrogen atom or a group which is hydrolyzed in vivo into a carboxy group, and G is a group represented by one of the formulae [G1], [G2], and [G3].
通式[1]或其药学上可接受的盐所代表的碳青霉烯化合物:其中R1是C1-C3烷基或羟基化的C1-C3烷基,R是氢原子或在体内水解为羧基的基团,G是由式[G1]、[G2]和[G3]之一所代表的基团。